These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10566114)
1. Psychotic side effects of psychostimulants: a 5-year review. Cherland E; Fitzpatrick R Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114 [TBL] [Abstract][Full Text] [Related]
2. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Varley CK; Vincent J; Varley P; Calderon R Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243 [TBL] [Abstract][Full Text] [Related]
3. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Ross RG Am J Psychiatry; 2006 Jul; 163(7):1149-52. PubMed ID: 16816217 [No Abstract] [Full Text] [Related]
4. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse. Heiligenstein E; Anders J J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682 [TBL] [Abstract][Full Text] [Related]
5. Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review. Martínez-Aguayo JC; Arancibia M; Meza-Concha N; Bustamante C; Pérez-Bracchiglione J; Madrid E Medwave; 2017 Jun; 17(5):e6980. PubMed ID: 28665917 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity. Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health. Moungnoi P; Maipang P J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770 [TBL] [Abstract][Full Text] [Related]
8. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder. Lakić A Vojnosanit Pregl; 2012 Feb; 69(2):201-4. PubMed ID: 22500377 [TBL] [Abstract][Full Text] [Related]
9. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362 [TBL] [Abstract][Full Text] [Related]
10. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895 [TBL] [Abstract][Full Text] [Related]
11. Treatment of attention-deficit/hyperactivity disorder. Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990 [TBL] [Abstract][Full Text] [Related]
12. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076 [TBL] [Abstract][Full Text] [Related]
13. Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses. Ross L; Sapre V; Stanislaus C; Poulton AS CNS Drugs; 2020 Jun; 34(6):643-649. PubMed ID: 32300972 [TBL] [Abstract][Full Text] [Related]
14. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C; Boidein F Encephale; 2001; 27(5):435-43. PubMed ID: 11760693 [TBL] [Abstract][Full Text] [Related]
15. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
16. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler. Lipkin PH; Butz AM; Cozen MA J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131 [TBL] [Abstract][Full Text] [Related]
17. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Kraemer M; Uekermann J; Wiltfang J; Kis B Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380 [TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522 [TBL] [Abstract][Full Text] [Related]
19. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Schertz M; Adesman AR; Alfieri NE; Bienkowski RS Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958 [TBL] [Abstract][Full Text] [Related]
20. Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution. Ghuman JK; Ginsburg GS; Subramaniam G; Ghuman HS; Kau AS; Riddle MA J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):516-24. PubMed ID: 11349695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]